SEC Form 4 · accession 0001179110-16-028956
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ganesh Venkataraman Kaundinya
Officer — Senior V.P., Research
Period of report
Aug 19, 2016
Accepted (ET)
Aug 23, 2016 · 5:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 19, 2016 | S | 396 | $12.04 | D | 455,716 | D | |
| Common Stock | Aug 19, 2016 | S | 426 | $12.04 | D | 455,290 | D | |
| Common Stock | Aug 22, 2016 | S | 227 | $12.10 | D | 455,063 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 25, 2009.